Impact investor

Frazier Healthcare Partners

Investor type

PE / VC

Founded

1991

AUM

$4 800 M

Location

Seattle, Washington, United States

$50-100 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series B, Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 27 July, 2026

Profile

GROWTH BUYOUTIntegrity, transparency and partnership are core to our long-term success.
The Frazier Growth Buyout team employs a thesis-driven, Executive in Residence-centric investment model which capitalizes on long-term secular trends

STRATEGY
IDEA GENERATION
Alongside industry thought leaders and executives, the Growth Buyout team generates investment theses through its annual Montana CEO Summit, bi-annual retreats and proactive outreach to the broader healthcare ecosystem.
INVESTMENT PROFILE
The firm invests in profitable, lower middle-market healthcare companies with $5-50 million in EBITDA and makes equity commitments ranging from $30-350 million. Investments take the form of buyouts, recapitalizations and corporate carveouts.
EXECUTIVE IN RESIDENCE
Leveraging its extensive network and human capital team, Frazier pairs proven executives with curated investment theses. This enables the pursuit of unique investment opportunities with the EIR assuming an Executive Chairman or CEO role.
CENTER OF EXCELLENCE TEAM
Serving as a shared resource to the fund's portfolio companies, the Frazier Center of Excellence team provides functional domain expertise in finance, human capital, legal, information technology and operations management.

OUR MISSION
To be the trusted capital partner to management teams and stakeholders who share our passion for creating and growing innovative companies that improve the quality, accessibility and affordability of healthcare.

OUR VISION
To be the world’s leading healthcare investment firm, improving the well-being of patients and all others we serve.

GROWTH BUYOUT STRATEGY
To partner actively with the most accomplished and innovative executive teams in the healthcare industry to develop compelling, growth-oriented companies which capitalize on long-term secular trends.

OUR CORE VALUES
Integrity
We choose the harder right over the easier wrong in serving the interests of patients, investors, portfolio companies, and other stakeholders in the healthcare ecosystem.

Empowerment
We invest in each other (early, often, and thoughtfully) and take ownership in a collaborative, compassionate and respectful manner to achieve firm goals.

Perseverance
We advance patient care with determination and purpose to positively impact our community.

Transparency
We promote constructively-candid and respectful dialogue to get to the right answers.

Social Impact
We will effect positive change in the areas of diversity, equity, inclusion, accessibility and the environment.

Performance
We deliver superior results to our investors and improved outcomes for everyone we serve.

Industry

Healthcare Services Marketing and Advertising Biotechnology Robotics HealthTech Medical Devices Pharmaceuticals MedTech Life Sciences Infrastructure AdTech

Region of investment

North America Europe

Frazier Healthcare Partners Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Frazier Healthcare Growth Buyout Fund XI, L.P.
Private Equity (PE)
Healthcare Services
Medical Devices
HealthTech
Series B
Late Stage (Series C+)
North America
Europe
$5-10 m
$2300 M
November 2024
Frazier Life Sciences XI, L.P.
Venture Capital (VC)
Biotechnology
Medical Devices
Pharmaceuticals
Pre-seed
Seed
Series A
North America
Europe
$5-10 m
$987 M
March 2022
Healthcare Growth Buyout Fund X LP
Private Equity (PE)
Healthcare Services
Medical Devices
Pharmaceuticals
HealthTech
Series B
Late Stage (Series C+)
North America
Europe
$5-10 m
$1400 M
May 2021
Frazier Life Sciences X
Venture Capital (VC)
Healthcare Services
Medical Devices
Life Sciences
HealthTech
Pre-seed
Seed
Series A
North America
Europe
$5-10 m
$617 M
January 2020
Frazier Life Sciences IX
Venture Capital (VC)
Biotechnology
Healthcare Services
Medical Devices
HealthTech
Pre-seed
Seed
North America
Europe
$5-10 m
$419 M
January 2018

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
1XguA3dbkUeLVr70 1XguA3dbkUeLVr70
1XguA3dbkUeLVr70
avatar
1XguA3dbkUeLVr70 1XguA3dbkUeLVr70
1XguA3dbkUeLVr70
avatar
1XguA3dbkUeLVr70 1XguA3dbkUeLVr70
1XguA3dbkUeLVr70
avatar
1XguA3dbkUeLVr70 1XguA3dbkUeLVr70
1XguA3dbkUeLVr70
avatar
1XguA3dbkUeLVr70 1XguA3dbkUeLVr70
1XguA3dbkUeLVr70
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about Frazier Healthcare Partners

Frazier Healthcare Partners is located in Seattle, Washington, United States.
Frazier Healthcare Partners was founded in 1991.
Frazier Healthcare Partners invests in companies and startups in Healthcare Services, Marketing and Advertising, Biotechnology, Robotics, HealthTech, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, Infrastructure, AdTech.
Frazier Healthcare Partners invests in companies and startups in North America, Europe.
Frazier Healthcare Partners invests in companies and startups at Seed, Series B, Series A.
Frazier Healthcare Partners usually invests $50-100 m on average.
Frazier Healthcare Partners has around $4 800m assets under management.
Frazier Healthcare Partners last fund was created/launched in 2024-11-11
Yes, Frazier Healthcare Partners is impact investor.